Table 2 Autoantibody specificity in patients with retinopathy and systemic cancer
From: Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy
Patient | ||||
|---|---|---|---|---|
# | Sex | Age | Cancer | Antibody Specificity |
P403 | F | 62 | Endometrium Ca | Recoverin [29]; see Fig. 3 |
P626 | F | 73 | Endometrium Ca | Recoverin |
P593 | F | 46 | Cervical Ca | Enolase |
P587 | F | 81 | Ovarian Ca | p35, p39, p46, p58 |
P405 | M | 62 | SCCL | Recoverin |
P407 | M | ?? | SCCL | Recoverin |
P409 | M | 64 | SCCL | Recoverin; see Fig. 3 |
P536 | F | 75 | SCCL | Recoverin |
P619 | M | 85 | SCCL | Recoverin |
P634 | M | 84 | Benign lung tumor | Recoverin |
P622 | M | 68 | Lung adenocarcinoma | p35 |
P402 | M | 84 | Colon Ca | Recoverin |
P692 | M | 58 | Colon | p35 |
P559 | F | 52 | Colon Ca | Bipolar cells [13] |
P624 | F | 47 | Colon Ca, skin Ca | p41 |
P596 | M | 66 | Bladder Ca | Enolase |
P568 | M | 78 | Skin melanoma | Enolase |
P578 | F | 44 | Skin melanoma | Enolase |
P474 | F | 35 | Skin melanoma | Enolase |
P618 | F | 35 | Skin melanoma | p35=transducin β [14] |
P566 | M | 59 | Skin melanoma | p35 |
P614 | M | 45 | Skin melanoma | p40 |
P570 | M | 70 | Squamous cell Ca of the skin | Recoverin |
P462 | F | 65 | Breast Ca primary, Recurrent Breast Ca | Enolase |
P488 | F | 85 | Breast Ca | Enolase |
P529 | F | 58 | Breast Ca | Enolase |
P726 | F | 74 | Breast Ca | Enolase |
P718 | F | 64 | Breast Ca in situ | Recoverin; see Fig. 3 |
P547 | M | 49 | Kidney Ca | p60 |
P711 | M | 64 | Tongue Ca, lung sarcoidosis | p58 |
P561 | F | 55 | Cutaneous B-cell Lymphoma | Enolase |
P651 | F | 81 | Adenocarcinoma of unknown primary discovered in a femoral lymph node | Arrestin |
P708 | F | 73 | Metastatic adenocarcinoma spread to liver of unknown primary | p60 |
P717 | F | 75 | Metastatic Ca spread to head of unknown primary | Enolase |